A detailed history of Iron Triangle Partners LP transactions in Insulet Corp stock. As of the latest transaction made, Iron Triangle Partners LP holds 264,041 shares of PODD stock, worth $62.7 Million. This represents 5.43% of its overall portfolio holdings.

Number of Shares
264,041
Holding current value
$62.7 Million
% of portfolio
5.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$161.02 - $206.98 $42.5 Million - $54.7 Million
264,041 New
264,041 $53.3 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $18 Million - $22.5 Million
80,000 New
80,000 $18.4 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $16.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.